An analytical review of growth hormone studies in children after renal transplantation

Area of Science:

• Pediatric Nephrology
• Transplantation Medicine
• Endocrinology

Background:

• Pediatric renal transplantation survival rates have improved, shifting focus to post-transplant rehabilitation and growth.
• Growth retardation remains a significant complication in children despite successful renal allografts.
• Recombinant human growth hormone (rhGH) has shown efficacy in improving growth in children with chronic renal failure before transplantation.

Purpose of the Study:

• To analyze the safety and efficacy of recombinant human growth hormone (rhGH) in children following renal transplantation.
• To review existing published data on rhGH use in pediatric transplant recipients.

Main Methods:

• Systematic review of seven published reports on rhGH therapy in children post-renal transplant.
• Analysis of patient demographics, rhGH dosage and duration, growth rates, renal function, and complications.

Main Results:

• Data from seven studies were analyzed to assess rhGH's impact on growth and safety in pediatric renal transplant patients.
• Specific patient characteristics, treatment parameters, and outcomes including growth, renal function, and adverse events were examined.

Conclusions:

• The use of rhGH in children after renal transplantation is controversial, with reported instances of acute rejection and graft loss.
• Further controlled studies are needed to establish the definitive safety and efficacy profile of rhGH in this population.